Free Vision Screenings Offer Kids A Chance For Brighter Future | OphthalmologyWeb: The Ultimate Online Resource for Ophthalmologists

Monday, April 16, 2012

Topix

ROGER BARONE / Wills Eye Institute Anisha Lampkin was having headaches, but it never occurred to the 16-year-old that the problem was her eyes.

All of the following drugs are FDA approved for the treatment of minimally classic subfoveal CNV in patients with neovascular AMD with evidence of recent disease progression (loss of vision, growth of CNV on FA, new macular hemorrhage) except for which one?
1. Pegaptanib sodium (Macugen)
2. Verteporfin (Visudyne PDT)
3. Ranibizumab (Lucentis)
4. None of the above
5. All of the above
Check The Answer

CareCloud Charts For Ophthalmology
Get all of the tools you need to deliver... view product
3nethra classic Ophthalmic Imaging Device
The 3nethra classic is a compact, ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us